A traditional southern African root that modestly eases the pain and stiffness of worn joints and the lower back, with the clearest signal for long-standing back pain. It may help preserve mobility and calm age-related inflammation while sparing conventional painkillers. Most people tolerate it well; the evidence remains uneven and how it works is unsettled. (Full Review)
| Marker | Target | Why |
|---|---|---|
| hs-CRP | <1.0 mg/L | Tracks the systemic inflammation the herb may modestly influence |
| ESR | Men <10–15; Women <15–20 mm/hr | Secondary marker of inflammatory joint activity |
| Fasting blood glucose | 70–90 mg/dL | Screens for additive blood-sugar lowering if on diabetes drugs |
| HbA1c | <5.4% | Longer-term glucose control if diabetic |
| INR | Per target (e.g., 2.0–3.0 on warfarin) | Detects bleeding-risk changes when combined with warfarin |
| ALT / AST | ALT <25 U/L (men), <20 (women) | Screens for rare liver stress during long-term use |
| eGFR / creatinine | eGFR >90 mL/min/1.73m² | Baseline organ-safety context, especially with other drugs |
| Blood pressure & resting heart rate | ~110–125/70–80 mmHg; 55–70 bpm | Screens for the theoretical cardiac effects |
Cadence: Reassess pain and function at 4 and 8–12 weeks, then every 6–12 months during long-term use; check INR within 1–2 weeks of starting or stopping warfarin; monitor blood glucose if on diabetes medication.